Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jaguar Animal Health Return on Tangible Equity 2014-2023 | JAGX

Current and historical return on tangible equity values for Jaguar Animal Health (JAGX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Jaguar Animal Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.04B $-0.02B 252.31%
2023-09-30 $-0.04B $-0.02B 216.22%
2023-06-30 $-0.05B $-0.02B 246.58%
2023-03-31 $-0.04B $-0.01B 218.18%
2022-12-31 $-0.05B $-0.02B 249.35%
2022-09-30 $-0.05B $-0.02B 337.50%
2022-06-30 $-0.05B $-0.02B 451.06%
2022-03-31 $-0.06B $-0.01B 1221.05%
2021-12-31 $-0.05B $-0.01B -6933.33%
2021-09-30 $-0.05B $-0.00B -2800.00%
2021-06-30 $-0.05B $0.01B 2250.00%
2021-03-31 $-0.04B $0.01B 579.31%
2020-12-31 $-0.04B $-0.01B 330.43%
2020-09-30 $-0.04B $-0.02B 318.18%
2020-06-30 $-0.04B $-0.01B 472.73%
2020-03-31 $-0.05B $-0.01B 450.00%
2019-12-31 $-0.05B $-0.01B 391.30%
2019-09-30 $-0.05B $-0.01B 331.03%
2019-06-30 $-0.04B $-0.02B 240.00%
2019-03-31 $-0.03B $-0.02B 209.23%
2018-12-31 $-0.03B $-0.02B 227.59%
2018-09-30 $-0.04B $-0.02B 270.97%
2018-06-30 $-0.03B $-0.02B 185.07%
2018-03-31 $-0.02B $-0.01B 165.52%
2017-12-31 $-0.02B $-0.02B 157.14%
2017-09-30 $-0.01B $-0.02B 64.86%
2017-06-30 $-0.01B $-0.01B 400.00%
2017-03-31 $-0.02B $-0.01B 1066.67%
2016-12-31 $-0.02B $-0.00B -1200.00%
2016-09-30 $-0.02B $0.00B -545.45%
2016-06-30 $-0.02B $0.00B -315.79%
2016-03-31 $-0.02B $0.01B -228.57%
2015-12-31 $-0.02B $0.00B -336.84%
2015-09-30 $-0.01B $0.01B -400.00%
2015-06-30 $-0.01B $0.01B -933.33%
2015-03-31 $-0.01B $-0.00B 880.00%
2014-12-31 $-0.01B $-0.00B 3600.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.085B $0.010B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.717B 31.19
Chugai Pharmaceutical (CHGCY) Japan $52.344B 23.40
Takeda Pharmaceutical (TAK) Japan $42.314B 8.57
Merck (MKGAF) Germany $21.381B 20.17
Astellas Pharma (ALPMY) Japan $17.916B 28.29
Sandoz Group AG (SDZNY) Switzerland $15.072B 0.00
Shionogi (SGIOY) Japan $14.270B 12.80
Neurocrine Biosciences (NBIX) United States $14.055B 38.47
United Therapeutics (UTHR) United States $11.801B 12.58
Catalent (CTLT) United States $10.131B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.681B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.131B 7.84
Revolution Medicines (RVMD) United States $6.179B 0.00
Ionis Pharmaceuticals (IONS) United States $5.761B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.410B 0.00
Alpine Immune Sciences (ALPN) United States $4.250B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.892B 0.00
Summit Therapeutics (SMMT) United States $3.355B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.063B 0.00
Corcept Therapeutics (CORT) United States $2.769B 25.09
Indivior (INDV) United States $2.464B 11.68
PTC Therapeutics (PTCT) United States $2.381B 0.00
Dyne Therapeutics (DYN) United States $2.268B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.027B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.986B 11.35
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Ardelyx (ARDX) United States $1.876B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.849B 17.99
Fusion Pharmaceuticals (FUSN) Canada $1.819B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.90
Soleno Therapeutics (SLNO) United States $1.592B 0.00
Xencor (XNCR) United States $1.451B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.434B 0.00
Pacira BioSciences (PCRX) United States $1.390B 13.21
4D Molecular Therapeutics (FDMT) United States $1.312B 0.00
Collegium Pharmaceutical (COLL) United States $1.238B 7.41
Enliven Therapeutics (ELVN) United States $1.123B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.102B 0.00
Cronos Group (CRON) Canada $1.089B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.055B 16.44
Centessa Pharmaceuticals (CNTA) United Kingdom $0.962B 0.00
Cassava Sciences (SAVA) United States $0.913B 0.00
Ocular Therapeutix (OCUL) United States $0.905B 0.00
USANA Health Sciences (USNA) United States $0.882B 14.43
ARS Pharmaceuticals (SPRY) United States $0.853B 0.00
Relay Therapeutics (RLAY) United States $0.838B 0.00
Sage Therapeutics (SAGE) United States $0.743B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.701B 0.00
Silence Therapeutics (SLN) United Kingdom $0.687B 0.00
Lyell Immunopharma (LYEL) United States $0.683B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.606B 0.00
ProKidney (PROK) United States $0.599B 0.00
Exscientia (EXAI) United Kingdom $0.598B 0.00
Siga Technologies (SIGA) United States $0.551B 7.05
Altimmune (ALT) United States $0.547B 0.00
OmniAb (OABI) United States $0.535B 0.00
Verve Therapeutics (VERV) United States $0.534B 0.00
KalVista Pharmaceuticals (KALV) United States $0.510B 0.00
Larimar Therapeutics (LRMR) United States $0.501B 0.00
Lexeo Therapeutics (LXEO) United States $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.443B 0.00
Korro Bio (KRRO) United States $0.440B 0.00
Bioventus (BVS) United States $0.432B 16.55
Tourmaline Bio (TRML) United States $0.404B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Harrow (HROW) United States $0.364B 0.00
Black Diamond Therapeutics (BDTX) United States $0.355B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.333B 0.00
Nanobiotix S.A (NBTX) France $0.314B 0.00
Organogenesis (ORGO) United States $0.301B 57.00
Aquestive Therapeutics (AQST) United States $0.300B 0.00
Fractyl Health (GUTS) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 18.59
Xeris Biopharma Holdings (XERS) United States $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.266B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Adherex Technologies (FENC) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Eliem Therapeutics (ELYM) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Zevra Therapeutics (ZVRA) United States $0.218B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Galectin Therapeutics (GALT) United States $0.201B 0.00
Century Therapeutics (IPSC) United States $0.197B 0.00
Telomir Pharmaceuticals (TELO) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.184B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Prelude Therapeutics (PRLD) United States $0.171B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Cardiol Therapeutics (CRDL) Canada $0.151B 0.00
Regulus Therapeutics (RGLS) United States $0.147B 0.00
CytoDyn (CYDY) United States $0.144B 0.00
Context Therapeutics (CNTX) United States $0.137B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
VAXART, INC (VXRT) United States $0.129B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.59
OptiNose (OPTN) United States $0.127B 0.00
Karyopharm Therapeutics (KPTI) United States $0.126B 0.00
FibroGen (FGEN) United States $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Inotiv (NOTV) United States $0.107B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Vivani Medical (VANI) United States $0.095B 0.00
AlloVir (ALVR) United States $0.094B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.00
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.062B 0.00
Protara Therapeutics (TARA) United States $0.061B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
Nutriband (NTRB) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
DURECT (DRRX) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Iterum Therapeutics (ITRM) Ireland $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.025B 0.00
Lyra Therapeutics (LYRA) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
BioVie (BIVI) United States $0.020B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.76